1. Home
  2. ZURA vs RECT Comparison

ZURA vs RECT Comparison

Compare ZURA & RECT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • RECT
  • Stock Information
  • Founded
  • ZURA 2022
  • RECT 1997
  • Country
  • ZURA United States
  • RECT Singapore
  • Employees
  • ZURA N/A
  • RECT N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • RECT
  • Sector
  • ZURA Health Care
  • RECT
  • Exchange
  • ZURA Nasdaq
  • RECT Nasdaq
  • Market Cap
  • ZURA 69.9M
  • RECT 66.1M
  • IPO Year
  • ZURA N/A
  • RECT 2024
  • Fundamental
  • Price
  • ZURA $1.30
  • RECT $4.70
  • Analyst Decision
  • ZURA Buy
  • RECT
  • Analyst Count
  • ZURA 7
  • RECT 0
  • Target Price
  • ZURA $14.33
  • RECT N/A
  • AVG Volume (30 Days)
  • ZURA 689.3K
  • RECT 1.8K
  • Earning Date
  • ZURA 08-08-2025
  • RECT 08-03-2025
  • Dividend Yield
  • ZURA N/A
  • RECT N/A
  • EPS Growth
  • ZURA N/A
  • RECT N/A
  • EPS
  • ZURA N/A
  • RECT 0.14
  • Revenue
  • ZURA N/A
  • RECT $33,502,767.00
  • Revenue This Year
  • ZURA N/A
  • RECT N/A
  • Revenue Next Year
  • ZURA N/A
  • RECT N/A
  • P/E Ratio
  • ZURA N/A
  • RECT $36.10
  • Revenue Growth
  • ZURA N/A
  • RECT 8.42
  • 52 Week Low
  • ZURA $0.97
  • RECT $2.70
  • 52 Week High
  • ZURA $5.07
  • RECT $7.68
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 58.73
  • RECT N/A
  • Support Level
  • ZURA $1.00
  • RECT N/A
  • Resistance Level
  • ZURA $1.45
  • RECT N/A
  • Average True Range (ATR)
  • ZURA 0.10
  • RECT 0.00
  • MACD
  • ZURA 0.02
  • RECT 0.00
  • Stochastic Oscillator
  • ZURA 66.67
  • RECT 0.00

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About RECT Rectitude Holdings Ltd Ordinary Shares

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks.

Share on Social Networks: